Cancer immunoediting by melanocyte differentiation antigen-specific T cells determines response to immune checkpoint inhibition
Lukas Flatz(University of Zurich), Michael Hölzel(University Hospital Bonn)
Cited by 0
Related Papers
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
|Journal for ImmunoTherapy of Cancer|2019|85
Druggable epigenetic suppression of interferon-induced chemokine expression linked to <i>MYCN</i> amplification in neuroblastoma
|Journal for ImmunoTherapy of Cancer|2021|39